You are here

Europe

Bluebird sets $1.8M price tag for blood-disease gene therapy

Bluebird sets $1.8M price tag for blood-disease gene therapy

Biopharma Dive

beta thalassemia

Flag link:

5 Things You'll Want to Watch With GW Pharmaceuticals

5 Things You'll Want to Watch With GW Pharmaceuticals

Motley Fool

Flag link:

Germany's Stada buys six of GSK's consumer brands, eyes further deals

Germany's Stada buys six of GSK's consumer brands, eyes further deals

Yahoo/Reuters

consumer health

Flag link:

Bluebird Bio’s Gene Therapy for Blood Disease Wins European Approval

Bluebird Bio’s Gene Therapy for Blood Disease Wins European Approval

Xconomy

beta thalassemia

Flag link:

EMA imposes formal limit on Xeljanz prescription as regulators continue to review safety concerns

EMA imposes formal limit on Xeljanz prescription as regulators continue to review safety concerns

Endpoints

post-marketing studies

Flag link:

EU universities are miserably lax at reporting clinical trial results, analysis suggests

EU universities are miserably lax at reporting clinical trial results, analysis suggests

Endpoints

clinical trial data

clinical trials

Flag link:

Lynparza on cusp of EU approval for advanced ovarian cancer

Lynparza on cusp of EU approval for advanced ovarian cancer

Pharmaforum

Flag link:

AZ and MSD’s Lynparza gets EU nod for hard-to-treat breast cancer

AZ and MSD’s Lynparza gets EU nod for hard-to-treat breast cancer

Pharmaforum

BRCA-mutant breast cancer

Flag link:

After falling short on prelim OS data, EMA tells Aveo it wants to see something better on its long suffering tivo this summer — or else

After falling short on prelim OS data, EMA tells Aveo it wants to see something better on its long suffering tivo this summer — or else

Endpoints

Flag link:

Teva wins EU nod for Ajovy migraine prophylactic

Teva wins EU nod for Ajovy migraine prophylactic

Drug Delivery Business News

Teva Pharmaceutical

Flag link:

AbbVie's massive Humira discounts are stifling Netherlands biosimilars: report

AbbVie's massive Humira discounts are stifling Netherlands biosimilars: report

Fierce Pharma

Flag link:

First gene therapy to treat rare blood disease nears European approval

First gene therapy to treat rare blood disease nears European approval

Stat

beta-thalassemia

Flag link:

Drug Sampling and Testing: EMA Releases 20 Year Report, Will Expand Program to Biosimilars

Drug Sampling and Testing: EMA Releases 20 Year Report, Will Expand Program to Biosimilars

RAPS.org

Flag link:

As Brexit row become increasingly anarchic, is UK’s reputation with pharma suffering?

As Brexit row become increasingly anarchic, is UK’s reputation with pharma suffering?

Pharmaforum

Flag link:

Sanofi may airlift medicines into UK after Brexit

Sanofi may airlift medicines into UK after Brexit

Pharmaforum

Flag link:

Aimmune's peanut allergy immunotherapy clears European PhIII with flying colors, paving way for first US, EU therapeutic approval

Aimmune's peanut allergy immunotherapy clears European PhIII with flying colors, paving way for first US, EU therapeutic approval

Endpoints

Flag link:

AZ’s diabetes drug Forxiga approved in EU for type 1 disease

AZ’s diabetes drug Forxiga approved in EU for type 1 disease

Pharmaforum

type 1 diabetes diabetes

Flag link:

Brexit delay offers biopharma more time to prepare for a no-deal

Brexit delay offers biopharma more time to prepare for a no-deal

BioCentury

Flag link:

EMA sounds its own safety alarm for Pfizer blockbuster, but they’re also not forcing a limit on dosing — yet

EMA sounds its own safety alarm for Pfizer blockbuster, but they’re also not forcing a limit on dosing — yet

Endpoints

rheumatoid arthritis

Flag link:

Roche clinches EU approval for MabThera in rare autoimmune indication — will it boost dwindling sales amid biosimiar competition?

Roche clinches EU approval for MabThera in rare autoimmune indication — will it boost dwindling sales amid biosimiar competition?

Endpoints

Flag link:

Pages